| Current Price | $2.52 | Mkt Cap | $455.0M |
|---|---|---|---|
| Open | $2.54 | P/E Ratio | -9.71 |
| Prev. Close | $2.52 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.50 - $2.62 | Volume | 1,238,061 |
| 52-Wk Range | $1.76 - $5.95 | Avg. Daily Vol. | 1,373,543 |
The Company develops and commercializes novel, proprietary products and technologies within the fields of blood safety and immunotherapy that provides safer and more medical options to patients in areas of unmet medical need.
| Current Price | $2.52 | Mkt Cap | $455.0M |
|---|---|---|---|
| Open | $2.54 | P/E Ratio | -9.71 |
| Prev. Close | $2.52 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.50 - $2.62 | Volume | 1,238,061 |
| 52-Wk Range | $1.76 - $5.95 | Avg. Daily Vol. | 1,373,543 |
The best Bull and Bear pitches based on recency and number of recommendations.
The Intercept system will be approved by the FDA for the US and this will become very profitable.
The biotech sector rebound is lifting up a lot of stocks that have been unfairly beaten down, and some others like Cerus whose weakness was more deserved. Revenues have been stagnant this year, which management initially blamed on the Euro and more… More
Read the most recent pitches from players about CERS.
Recs
sk2129
(32.52)
Submitted: 11/30/2015 4:37:56 PM :
Start Price:
$4.49
NASDAQ:CERS Score:
-148.65
baker bros.
Recs
Saveupnow
(< 20)
Submitted: 2/13/2014 2:25:47 PM :
Start Price:
$7.29
NASDAQ:CERS Score:
-200.59
FDA approval expected this year, need cleaner blood and plasma
Recs
IFindKaching
(< 20)
Submitted: 4/18/2011 12:38:26 PM :
Start Price:
$2.74
NASDAQ:CERS Score:
-239.00
CERS is the best option in the critical market for blood supply protection. Already accepted in Europe and other parts of the world, it's only a matter of time for FDA approval in the US. When that happens...
Find the members with the highest scoring picks in CERS.
ericsmu (46.30) Score: +294.57
The Score Leader is the player with the highest score across all their picks in CERS.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| ericsmu | 46.30 | 10/4/2006 |
|
3W | $5.60 | -55.09% | +239.48% | +294.57 | 0 Comment | |
| BicaChica | 82.84 | 3/26/2008 |
|
5Y | $5.86 | -57.08% | +233.02% | +290.10 | 0 Comment | |
| ahknaten74 | 93.32 | 3/24/2008 |
|
NS | $4.79 | -47.49% | +234.53% | +282.03 | 0 Comment | |
| MassProduced | 96.98 | 2/16/2007 |
|
NS | $5.52 | -54.44% | +213.84% | +268.28 | 0 Comment | |
| NatedoggGT1 | 86.16 |
|
|
3Y | $9.71 | -74.10% | +192.30% | +266.40 | 0 Comment | |
| mifollower | 22.08 | 1/21/2011 |
|
NS | $3.59 | -29.94% | +233.68% | +263.62 | 0 Comment | |
| FundamentalGamma | < 20 | 12/10/2007 |
|
NS | $6.96 | -63.86% | +197.82% | +261.69 | 1 Comment | |
| clover0958 | 72.75 | 5/9/2007 |
|
3M | $5.77 | -56.41% | +201.51% | +257.92 | 0 Comment | |
| Morgan5588 | < 20 | 5/21/2012 |
|
5Y | $3.37 | -25.37% | +230.40% | +255.77 | 0 Comment | |
| dwn88ir | 40.46 | 5/21/2012 |
|
5Y | $3.49 | -27.94% | +227.43% | +255.37 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
